Why More Capital Has Not Made African Companies More Durable
By Liza Akinyi
Africa does not have a capital problem.
Over the past decade, billions have flowed into venture-backed companies across Kenya, Nigeria, South Africa and Egypt. Funds have closed. Rounds have been announced. Valuations have climbed, and entire ecosystems have formed around early-stage finance, complete with accelerators, angel networks, demo days and the vocabulary that travels with them. By almost any measure of activity, the decade has been a success.
And yet the fragility remains. Companies that raised well are quietly winding down. Others are alive but smaller than they were two years ago, having cut the teams and the markets they expanded into. The pattern is common enough now that it has stopped being surprising, which is itself worth pausing on.
So perhaps the question is not the volume of capital. Perhaps it is the alignment of it.
Capital carries assumptions, and those assumptions travel
Much of the capital entering African markets is structured with assumptions imported from more stable environments. It assumes predictable regulation, reliable infrastructure, deep exit markets and currency stability. The timelines assume scale at a certain speed. The return profiles assume liquidity pathways that remain thin locally. The governance expectations assume an institutional depth that many markets are still building, in good faith and at their own pace.
None of that is malice, and very little of it is even visible to the people on either side of the table. Terms are inherited. A fund structure that worked elsewhere is the structure that gets raised, because that is what the limited partners behind it understand and will commit to. The assumptions arrive inside the money, unstated.
Founders then respond rationally. They build models that fit investor appetite. They optimise for growth curves that travel well in pitch rooms. They prioritise sectors that global capital already understands, which is why certain sectors are crowded and others, often the ones solving the more stubborn problems, are not. They compress timelines. They stretch burn. They chase scale before the internal machinery is mature enough to carry it.
This is not incompetence. It is adaptation, and it is intelligent adaptation to the incentive actually in front of them.
But adaptation to misaligned capital produces distorted companies. A business engineered primarily for venture velocity struggles when the market moves slower than the model assumed. When the exit is delayed. When follow-on funding tightens, as it has. When currency volatility erodes a margin that was thin to begin with. At that point we reach for the familiar explanation and say there is not enough capital in the market.
Capital that demands one kind of outcome while the market structurally supports another will always produce that tension. Alignment matters more than abundance.
The half of the problem that sits inside the company
There is a second half to this, and it is less comfortable because it sits with founders rather than with funders.
Africa does not lack founders who can raise capital. An entire generation has become fluent in the language of venture: pitch cadence, narrative arc, growth curve, valuation mechanics. Fundraising has become a visible marker of competence, and the fluency is real.
But raising capital and allocating capital are two different disciplines. One is persuasive. The other is architectural.
In many companies the round becomes the milestone, the press cycle becomes the validation, and the valuation becomes the signal of progress. Inside the business, allocation discipline lags behind acquisition skill. Headcount expands before revenue has stabilised. A second market opens before operational depth exists in the first. Marketing scales ahead of any clear read on unit economics. Technology teams grow faster than the governance frameworks needed to hold them.
This is not recklessness either. It is conditioning. When an ecosystem rewards capital raised more visibly than return on capital invested, behaviour follows the reward, and it would be strange if it did not.
Allocation is not about spending less. It is about sequencing correctly, and the questions it asks are unglamorous. What must be proven before headcount doubles? What operational machinery must exist before entering a second market? What governance discipline must be in place before scaling burn? What does durability look like if the next round takes eighteen months longer than planned, which in the current market is not a pessimistic assumption but a reasonable one?
These questions rarely trend. They determine, over time, whether a company compounds or contracts.
In my own practice I have watched ventures with modest capital outlast better funded peers, and the difference was rarely brilliance. They treated capital as finite leverage rather than as fuel for optics. They expanded in layers. They tied spend to validated traction rather than to projected traction. They built internal reporting discipline before external storytelling, which is the reverse of the usual order.
Capital amplifies whatever discipline already exists. Where the underlying machinery is weak, more capital accelerates fragility. Where it is strong, capital accelerates endurance. Fundraising is an event. Allocation is a philosophy, and institutions are built by the latter.
What this asks of the people deploying capital
If the alignment argument holds, then the design question sits upstream of the founder, with the institutions writing the cheques.
Capital that is patient where markets are maturing, governance-focused where institutions are forming, and realistic about timelines in volatile environments produces companies that are designed differently from the first week. Different incentives, different architecture, a different endurance profile. That is not concessionary capital and it is not lowered expectations. It is capital whose structure matches the structural reality of the market it has entered.
For a development finance institution or a fund manager, three questions follow from this, and none of them are difficult to ask. Does the timeline in the term sheet reflect the liquidity pathways that actually exist in this market, or the ones that exist elsewhere? Does the portfolio support the building of allocation discipline, or does it only measure deployment? And when a company underperforms against a model built on imported assumptions, is that read as a failure of the founder or as evidence that the assumptions need revisiting?
I work with institutions on exactly this question, and what I see most often is that the diligence is thorough on the business and thin on the readiness of the person who has to run it. That gap is where a great deal of capital is quietly lost.
What to do with this
If you are a founder, the useful exercise is not to complain about the capital available to you but to be honest about which of your decisions were made for your business and which were made for your next round. Most founders can name two or three within a few minutes of being asked properly.
If you are deploying capital, the useful exercise is to look at one company in your portfolio that is struggling and ask whether the model it was funded against was ever achievable in the market it operates in.
More capital does not solve fragility. Without alignment, it amplifies it. That is the harder conclusion, and it is the one that actually changes what any of us do on Monday.